Hikma Pharmaceuticals USA Inc.


    Job Location US-NJ-Cherry Hill
    Posted Date 1 week ago(10/12/2018 6:25 PM)
    Job ID
    Job Function
  • Overview

    This position is located in Cherry Hill, NJ for 2nd Shift

    In accordance with Hikma SOP’s and cGMP’s, the Production Operator II is responsible for the inspection, labeling and packaging of finished drug product. The Production Operator II position will execute these tasks manually, or will be responsible for operating equipment that performs these functions.


    1. Performs visual inspection of drug product in accordance with SOP’s and cGMP’s.
    2. Performs manual packaging functions as required.
    3. Sets up, maintains and operates various pieces of computerized and manual inspection/packaging equipment.
    4. Performs line clearance of assigned production lines as required.
    5. Adheres to cGMP’s and internal SOP’s as required.
    6. Responsible for maintaining the quality of machine output and product integrity.
    7. Responsible for maintaining a clean production environment during shift.
    8. Completes and maintains applicable log book and batch record paperwork as required.
    9. Reports both machine and manual deviations to area supervisor or designee.
    10. Performs other related production functions, such as: Inspector, Packer, Catching, etc. as determined by supervisor and/or management.


    To perform this job successfully, an individual must be able to perform each essential duty satisfactorily.

    A close visual acuity (eye exam) is required.

    1. Employee may be required to lift 5 – 40 pounds.
    2. Employee may be required to stand continually throughout the shift.
    3. Job involves frequent bending, twisting, pushing, pulling and lifting.
    4. The noise level of the job environment is moderate. Hearing protection is provided and may be required at times.
    5. H.S. Diploma or equivalent is required. Some college and/or college degree preferred.


    Sorry the Share function is not working properly at this moment. Please refresh the page and try again later.
    Share on your newsfeed